WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013116656) IMMUNOSTIMULATORY COMPOSITIONS, PARTICLES, AND USES RELATED THERETO
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/116656    International Application No.:    PCT/US2013/024355
Publication Date: 08.08.2013 International Filing Date: 01.02.2013
IPC:
A61K 39/00 (2006.01), A61K 39/12 (2006.01), A61P 35/00 (2006.01), A61P 31/12 (2006.01)
Applicants: EMORY UNIVERSITY [US/US]; Office of Technology Transfer 1599 Clifton Road NE, 4th Floor Atlanta, Georgia 30322 (US)
Inventors: SELVARAJ, Periasamy; (US)
Agent: MASON, James C.; Emory University Office of Technology Transfer 1599 Clifton Road NE, 4th Floor Atlanta, Georgia 30322 (US)
Priority Data:
61/594,754 03.02.2012 US
Title (EN) IMMUNOSTIMULATORY COMPOSITIONS, PARTICLES, AND USES RELATED THERETO
(FR) COMPOSITIONS IMMUNOSTIMULATRICES, PARTICULES ET APPLICATIONS ASSOCIÉES
Abstract: front page image
(EN)In some embodiments, described herein is a method of tumor treatment or tumor vaccination. The method generally comprises applying to a human being in need thereof a tumor therapeutic composition or tumor vaccine defined herein. The tumor therapeutic composition or tumor vaccine can be produced by protein transfer of glycosyl-phosphatidylinositol (GPI)-anchored immunostimulatory or costimulatory molecules.
(FR)Dans certains modes de réalisation, la présente invention concerne un procédé de traitement d'une tumeur ou de vaccination anti-tumorale. Le procédé consiste de façon générale à administrer à un être humain en ayant besoin une composition thérapeutique anti-tumorale ou un vaccin anti-tumoral défini ici. La composition thérapeutique anti-tumorale ou le vaccin anti-tumoral peut être produit(e) par transfert protéique de molécules immunostimulatrices ou costimulatrices dotées d'ancres GPI (glycosyl-phosphatidylinositol).
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)